NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
MELBOURNE,Australia and BRUSSELS,Dec. 31,2024-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company)and the Brussels-based Oncidium foundation today announce that results for the